LevitasBio is a biotechnology company focused on advancing cellular analysis through innovative label-free cell enrichment technologies. Its platform enables researchers to isolate high-quality, viable cells without labels or magnetic beads, improving downstream analysis accuracy in genomics, immunology, and translational research.
Campaign Objective
LevitasBio partnered with Group Futurista to host a targeted virtual leadership summit designed to:
- Engage senior life sciences, genomics, and research decision-makers
- Demonstrate the scientific advantages of label-free cell enrichment
- Generate enterprise-qualified demand opportunities
- Position LevitasBio as an innovation leader in next-generation cell analysis technologies
Target Audience Roles
- Chief Scientific Officers
- Research Directors
- Genomics Leaders
- Lab Operations Heads
- Translational Medicine Executives
- Immunology Specialists
- Biotech Innovation Leaders
Event Metrics
| Metric | Result |
| Total Registrations | 329+ |
| Live Attendance | 41% (approx. 135 attendees) |
| On-Demand Views | 251+ within 30 days |
| Industries Represented | 25 sectors |
| Director Level & Above | 78% |
Event Delivery & Engagement
The summit featured:
- Strategic keynote on the evolution of cell analysis technologies
- Scientific panel on improving sample integrity for downstream assays
- Technical demonstration of label-free cell enrichment workflows
- Interactive polling on research bottlenecks
- Live Q&A and moderated expert discussions
Engagement Highlights
- Strong participation from research and laboratory leaders
- 66 audience questions submitted live
- Average viewing duration: 40 minutes
- Peak engagement during workflow demonstration session
- Active knowledge sharing among genomics and biotech professionals
Lead Quality & Conversations Generated
Qualified Leads Delivered: 171 MQLs
Lead Profile
- Research institutions advancing cellular analysis programs
- Biotech companies optimizing sample preparation workflows
- Clinical labs improving cell isolation accuracy
- Pharma organizations supporting precision medicine studies
Key Conversation Themes
- Improving cell viability and sample purity
- Enhancing downstream sequencing results
- Reducing variability in cell preparation methods
- Scaling research workflows efficiently
- Adopting next-generation cell isolation technologies
Post-Event Interest Signals
Participants requested:
- Technical demonstrations
- Application-specific consultations
- Pilot study discussions
- Workflow optimization sessions
Results Snapshot
| KPI | Outcome |
| Qualified Leads | 171 |
| Senior Decision Makers | 78% |
| Avg Engagement | 40 mins |
| Questions Asked | 66 |
| Follow-Up Requests | Strong |
| Pipeline Potential | Significant |
Outcome
Through this focused virtual leadership summit, LevitasBio successfully:
- Engaged high-intent life sciences and research leaders
- Strengthened positioning as a next-generation cell analysis innovator
- Generated strong enterprise pipeline opportunities
- Initiated strategic scientific discussions with qualified prospects
- Achieved measurable ROI from a single campaign partnership
